Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs
Open Access
- 2 October 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (20) , 3008-3022
Abstract
Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D2 (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular biological techniques, and most drugs designed to target DRD2 are ligands for many other receptors. Here, we developed probes able to both covalently bind to DRD2 using photoaffinity labeling and provide a chemical handle for detection or affinity purification. These probes behaved like good DRD2 agonists in traditional biochemical assays and were able to perform in chemical-biological assays of cell and receptor labeling. Rat whole brain labeling and affinity enrichment using the probes permitted proteomic analysis of the probes' interacting proteins. Bioinformatic study of the hits revealed that the probes bound noncanonically targeted proteins in Parkinson's disease network as well as the retrograde endocannabinoid signaling, neuronal nitric oxide synthase, muscarinic acetylcholine receptor M1, GABA receptor, and dopamine receptor D1 (DRD1) signaling networks. Follow-up analysis may yield insights into how this pathway relates specifically to Parkinson's disease symptoms or provide new targets for treatments. This work reinforces the notion that the combination of chemical biology and omics-based approaches provides a broad picture of a molecule's "interactome" and may also give insight into the pleiotropy of effects observed for a drug or perhaps indicate new applications.Keywords
All Related Versions
This publication has 73 references indexed in Scilit:
- The role of nitric oxide in pre-synaptic plasticity and homeostasisFrontiers in Cellular Neuroscience, 2013
- Long-term use of pramipexole in the management of restless legs syndromeSleep Medicine, 2012
- Synthesis and Pharmacological Evaluation of Thiazole and Isothiazole Derived ApomorphinesArchiv der Pharmazie, 2009
- Design, Synthesis, and Evaluation of Potent and Selective Ligands for the Dopamine 3 (D3) Receptor with a Novel in Vivo Behavioral ProfileJournal of Medicinal Chemistry, 2008
- The genetic design of signaling cascades to record receptor activationProceedings of the National Academy of Sciences, 2008
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Coupling of agonist binding to channel gating in the GABAA receptorNature, 2003
- Tryptophan scanning mutagenesis in TM4 of the GABAA receptor α1 subunit: implications for modulation by inhaled anesthetics and ion channel structureNeuropharmacology, 2002
- Novel 4,5,6,7-tetrahydrobenzothiazole dopamine agonists display very low stereoselectivity in their interaction with dopamine receptors.Bioorganic & Medicinal Chemistry Letters, 1991
- Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonistsJournal of Medicinal Chemistry, 1986